Why Is Esperion Therapeutics (ESPR) Up 14.2% Since Last Earnings Report?

It has been about a month since the last earnings report for Esperion Therapeutics (ESPR) . Shares have added about 14.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Esperion Therapeutics due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Esperion Q1 Earnings an ...